Outcomes for COPD pharmacological trials: from lung function to biomarkers. Review uri icon

Overview

abstract

  • The American Thoracic Society/European Respiratory Society jointly created a Task Force on "Outcomes for COPD pharmacological trials: from lung function to biomarkers" to inform the chronic obstructive pulmonary disease research community about the possible use and limitations of current outcomes and markers when evaluating the impact of a pharmacological therapy. Based on their review of the published literature, the following document has been prepared with individual sections that address specific outcomes and markers, and a final section that summarises their recommendations.

authors

  • Cazzola, M
  • MacNee, W
  • Martinez, Fernando J
  • Rabe, K F
  • Franciosi, L G
  • Barnes, P J
  • Brusasco, V
  • Burge, P S
  • Calverley, P M A
  • Celli, B R
  • Jones, P W
  • Mahler, D A
  • Make, B
  • Miravitlles, M
  • Page, C P
  • Palange, P
  • Parr, D
  • Pistolesi, M
  • Rennard, S I
  • Rutten-van Mölken, M P
  • Stockley, R
  • Sullivan, S D
  • Wedzicha, J A
  • Wouters, E F

publication date

  • February 1, 2008

Research

keywords

  • Advisory Committees
  • Biomarkers
  • Clinical Trials as Topic
  • Pulmonary Disease, Chronic Obstructive

Identity

Scopus Document Identifier

  • 40649117704

Digital Object Identifier (DOI)

  • 10.1183/09031936.00099306

PubMed ID

  • 18238951

Additional Document Info

volume

  • 31

issue

  • 2